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The epidermis functions to create a barrier to 
protect from water loss and exclude foreign sub­
stances and microorganisms. It consists of a multi­
layered stratified epithelium with viable basal, 
spinous, and granular layers and a dead cornified 
layer (stratum corneum). The epidermal barrier 
is maintained and continuously regenerated 
by terminally differentiating keratinocytes, in a 
highly organized process called cornification 
(Candi et al., 2005). After the proliferating basal 
keratinocytes detach from the underlying base­
ment membrane, they are committed to terminal 
differentiation and form the cornified layer, 
which consists of flattened cell remnants (cor­
neocytes) surrounded by insoluble lipids. These 
detached suprabasal keratinocytes undergo several 
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ADAM17 (a disintegrin and metalloproteinase 17) is ubiquitously expressed and cleaves 
membrane proteins, such as epidermal growth factor receptor (EGFR) ligands, l-selectin, and 
TNF, from the cell surface, thus regulating responses to tissue injury and inflammation. 
However, little is currently known about its role in skin homeostasis. We show that mice 
lacking ADAM17 in keratinocytes (A17KC) have a normal epidermal barrier and skin archi-
tecture at birth but develop pronounced defects in epidermal barrier integrity soon after birth 
and develop chronic dermatitis as adults. The dysregulated expression of epidermal differen-
tiation proteins becomes evident 2 d after birth, followed by reduced transglutaminase (TGM) 
activity, transepidermal water loss, up-regulation of the proinflammatory cytokine IL-36, 
and inflammatory immune cell infiltration. Activation of the EGFR was strongly reduced in 
A17KC skin, and topical treatment of A17KC mice with recombinant TGF- significantly 
improved TGM activity and decreased skin inflammation. Finally, we show that mice lacking 
the EGFR in keratinocytes (EgfrKC) closely resembled A17KC mice. Collectively, these results 
identify a previously unappreciated critical role of the ADAM17–EGFR signaling axis in 
maintaining the homeostasis of the postnatal epidermal barrier and suggest that this pathway 
could represent a good target for treatment of epidermal barrier defects.
© 2012 Franzke et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months it 
is available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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resistance and insolubility of the CE because they cross­link its 
structural components like involucrin, loricrin, filaggrin, and the 
small proline­rich proteins. Specifically, the cytosolic TGM3 
cross­links various CE components into small oligomers, which 
are then translocated and cross­linked onto the growing CE at 
the cell periphery by the membrane­bound TGM1 (Hitomi, 
2005). A well balanced equilibrium of corneocyte differentiation 
and their controlled release from the skin surface (desquamation) 
is crucial to maintain the epidermal barrier and ensure its renewal 
every 3 wk (Blanpain and Fuchs, 2009). The physiological rele­
vance of both TGMs in skin is highlighted by the lethality of 
Tgm1/ and Tgm3/ mice (Kim et al., 2002).
transcriptional and morphological changes during their trans­
location to the skin surface. Although these morphogenetic 
changes during epidermal stratification are well documented, 
the molecular processes of terminal differentiation, which are 
crucial for the development and homeostasis of the epidermal 
barrier, are not well understood (Blanpain and Fuchs, 2009).
The cornification process of granular keratinocytes begins 
with the formation of the cornified envelope (CE), an insoluble 
protein structure which is stabilized by trans­glutaminases 
(TGMs). It replaces the plasma membrane and functions as a 
scaffold for the attachment of insoluble lipids (Candi et al., 
2005). The TGMs 1 and 3 are responsible for the characteristic 
Figure 1. Keratinocyte-specific ADAM17 deficiency results in postnatal epidermal barrier defects. (A) Western blot analysis to detect ADAM17 
in lysates from P3 epidermal splits of control (Ctrl) or A17KC mice. (B) Newborn A17KC mice and their littermate controls. 7.5% of A17KC newborn mice 
had open eyes at birth, indicated by arrow. (C) Dry scaly skin of A17KC mice at P19. (D) Body weight of A17KC versus control mice at different ages (n ≥ 4). 
(E) Survival curve of A17KC mice (n = 100) versus controls (Ctrl, n = 25). Mantel-Cox test: ***, P < 0.001. (F) Serum sodium concentration of A17KC  
versus control mice between P15 and P25. (G) Toluidine blue dye penetration assays were performed with newborn mice (P1), P10, and P15 animals indi-
cating outside-in barrier defects (n = 3 per age group). Blue staining of the umbilical cord and the cut tail at P1 is a positive control. (H) TEWL in A17KC 
and control littermates at P8, P10, P15, and P19 (n ≥ 4 for P8; n ≥ 8 for P10, P15, and P19). (I) Preparation of CEs from 25-mm2 P15 back skin samples.  
CE clustering is indicated by the arrow. Results: mean ± SD. Student’s t test: *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bar, 20 µm.
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Jackson et al., 2003; Sternlicht et al., 2005) and is responsible 
for the cleavage of pro­TNF (Black et al., 1997; Moss et al., 
1997). Mice lacking ADAM17 die at birth, presumably as a 
result of defects in heart development, although other organs, 
such as the lung, skin, and mammary epithelia were also 
affected (Peschon et al., 1998; Jackson et al., 2003; Sternlicht 
et al., 2005). In that respect, Adam17/ mice nearly pheno­
copy Egfr/ mice or mice lacking the EGFR ligands TGF­, 
HB­EGF, or amphiregulin, indicating an in vivo relevance of 
ADAM17 in EGFR processing (Peschon et al., 1998; Jackson 
et al., 2003; Blobel, 2005; Sternlicht et al., 2005). This 
notion is supported by cell­based assays, in which the shedding 
of several EGFR ligands depended on ADAM17 (Sahin et al., 
2004). Moreover, ADAM17­dependent EGFR activation 
protects hepatocytes from apoptosis during drug­induced 
toxicity (Murthy et al., 2010) and supports intestinal prolifer­
ative regeneration in experimental colitis (Chalaris et al., 
2010). Because very little is currently known about the role 
of ADAM17 in postnatal epithelial barrier homeostasis under 
physiological conditions, the goal of this study was to analyze 
how conditional inactivation of ADAM17 in kerati­
nocytes (A17KC) affects the development and main­
tenance of the epidermal barrier.
RESULTS
Keratinocyte-specific ADAM17 deficiency results  
in severe postnatal epidermal barrier defects
To analyze the function of ADAM17 in skin, we 
crossed mice with floxed alleles of ADAM17 (Horiuchi 
et al., 2007) with keratin14­Cre knockin mice (Krt14-Cre) 
to generate mice lacking ADAM17 in keratinocytes 
(A17KC). Western blot analysis confirmed the dele­
tion of ADAM17 in epidermal splits from A17KC mice 
(Fig. 1 A). An analysis of the expression pattern of 
Krt14­Cre using the ROSA26­lacZ reporter con­
firmed that it was restricted to the squamous epithelia 
The epidermal growth factor receptor (EGFR) is most 
prominently expressed in proliferating basal keratinocytes 
and to a lesser degree in suprabasal keratinocytes. It sup­
ports basal keratinocyte proliferation and delays apoptosis in 
suprabasal keratinocytes that have lost their interaction with 
the matrix (Pastore and Mascia, 2008; Pastore et al., 2008; 
Schneider et al., 2008). EGFR deficiency causes defects in 
hair follicle development and immature epidermal differenti­
ation with inflammatory skin reactions (Miettinen et al., 
1995; Murillas et al., 1995; Sibilia and Wagner, 1995; Threadgill 
et al., 1995; Sibilia et al., 2003), and anti­EGFR therapy 
in cancer patients commonly induces dermatologic side ef­
fects including xerotic itchy skin (Lacouture, 2006). Although 
these observations corroborate the significance of EGFR sig­
naling in skin homeostasis, little is currently known about the 
role of EGFR signaling in maintaining the epidermal barrier 
and in suppressing chronic inflammatory skin disease.
ADAM17 (a disintegrin and metalloproteinase 17) is 
a membrane­anchored metalloproteinase that is a crucial 
upstream regulator of EGFR signaling (Peschon et al., 1998; 
Figure 2. Decreased TGM activity and altered expression 
of epidermal differentiation markers in A17KC skin.  
(A) Western blots of epidermis lysates analyzing epidermal kera-
tin1, keratin14, loricrin, and involucrin expression in A17KC skin 
(quantification: n = 5). (B) In situ detection of TGM activity in 
A17KC and control epidermis at P2 and P10, with TGM activity 
in the stratum granulosum of control epidermis indicated by 
arrows (quantification: n = 6). (C) Quantitative RT-PCR from 
total RNA of P10 A17KC skin analyzing TGM1, TGM3, and kera-
tin14 (n = 4). (D) Quantitative immunoblot analysis from P10 
skin lysates analyzing TGM1 and TGM3 in A17KC animals (n = 4). 
(E) Detection of serine protease activity in P10 skin with SBTI 
Alexa Fluor 488 conjugates in the stratum granulosum and 
stratum corneum in control skin (arrows) and in A17KC skin  
(n = 3). The negative controls with an excess of unlabeled SBTI 
resulted in diminished signals. (F) RT-PCR analysis from total 
RNA derived from P10 skin for serpina3a, serpina3n, and kera-
tin14 (n = 4). The dashed lines in B and E represent the base-
ment membrane. Bars, 20 µm. Results: mean ± SD. Students  
t test: *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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and P10 pups was completely resistant to toluidine blue pen­
etration, whereas P15 animals showed dye permeability in 
the mechanically stressed areas, including the face around 
their snout, genitals, anus, and paws (Fig. 1 G). Transepider­
mal water loss (TEWL) of the skin surface was first detectable 
at P10, and subsequently increased with age, as documented 
at P15 and P19 (Fig. 1 H), indicating severe inside­out bar­
rier defects. Because epidermal lipids are crucial to form the 
protective barrier against water loss in the stratum corneum, 
we stained P15 skin sections with the lipophilic dye Nile red. 
No significant differences in epidermal lipid content and dis­
tribution were seen in A17KC versus control mice (unpub­
lished data). Impaired integrity of the CE has been linked to 
skin barrier defects (Sevilla et al., 2007). CE preparations de­
rived from P15 biopsies of A17KC back skin showed 50% 
reduced size and were clustered in conglomerates that were 
not seen in preparations of control skin (Fig. 1 I), indicating 
abnormal development and an immature state.
Dysregulated epidermal differentiation markers  
and decreased TGM activity in A17KC skin
Skin integrity depends on the renewal of terminally differenti­
ated keratinocytes, which assemble the CE. Histological analy­
sis of back skin from A17KC mice and littermate controls at 
P2 failed to uncover evident structural defects within the epi­
dermal layers or differences in the number of proliferating 
basal keratinocytes (unpublished data). In contrast, epidermal 
differentiation was significantly altered, with increased pro­
duction of the early differentiation marker keratin1 and the 
terminal differentiation marker loricrin, a major component 
of the CE (Koch et al., 2000), and decreased production of 
involucrin and TGM3, which are needed to initiate cornifica­
tion on the skin surface, whereas the expression of keratin 14, 
a structural component of the basal layer, remained unchanged 
(Fig. 2 A). Thus, epidermal ADAM17 deficiency increases 
early and dysregulates late keratinocyte differentiation.
The TGMs 1 and 3 are crucial to forming 
the CE (Hitomi, 2005). When we used a fluor­
ometric in situ assay with a synthetic TGM 
substrate (Raghunath et al., 1998) to evaluate 
whether the TGM expression or activity was 
altered in A17KC keratinocytes, we found 
comparable epidermal TGM activity to control 
littermates at P2 but significantly reduced 
activity in A17KC epidermis at P10 (Fig. 2 B). 
of the skin and mucosa, as previously reported (Wang et al., 
1997; not depicted).
Newborn A17KC mice had no evident skin defects (Fig. 1 B) 
or histological abnormalities in their epidermis (not depicted). 
About 7.5% of A17KC mice were born with open eyes (Fig. 1 B), 
whereas all Adam17/ mice (complete knockout) have open 
eyes at birth (Peschon et al., 1998; Horiuchi et al., 2007), sug­
gesting that other cells besides keratinocytes contribute to this 
phenotype in Adam17/ mice. However, starting at P19, 
macroscopic epidermal defects became evident, with dry scaly 
skin in the face, the area surrounding the snout, the ventral 
neck and chest (Fig. 1 C), and the tail (not depicted), suggesting 
a compromised epidermal barrier in A17KC mice.
Epidermal barrier defects lead to water loss, weight loss, 
electrolyte imbalances, and loss of skin turgor (Shwayder and 
Akland, 2005). Although the Mendelian distribution of the 
offspring of Adam17flox/wt/Krt14-Cre × Adam17flox/flox mice 
was normal (not depicted) and A17KC mice had a normal 
weight compared with littermate controls at birth and the 
first days thereafter, their weight was reduced by 5% at post­
natal day 8 (P8) and 30% at P20 (Fig. 1 D). Most of the 
A17KC mice died between P21 and P29, although some 
lived up to 6 mo (Fig. 1 E). The mean weight of surviving 
A17KC mice was about half that of control animals (Fig. 1 D). 
Moreover, A17KC mice had reduced skin turgor and sig­
nificantly increased serum sodium levels (Fig. 1 F). The 
combination of hypernatremia and weight loss suggested 
dehydration as the underlying cause. None of the other gen­
otypes (Adam17wt/wt/Krt14-Cre, Adam17flox/wt/Krt14-Cre, 
Adam17flox/wt, or Adam17flox/flox, referred to as Ctrl) displayed 
any evident phenotype (unpublished data). Together, these 
data suggest that the postnatal lethality in A17KC mice was 
caused by water loss as the result of an epidermal barrier defect 
that developed after birth.
We next used a dye penetration assay to examine the in­
tegrity of the skin barrier. The epidermis of newborn mice 
Figure 3. A17KC keratinocytes exhibit cell au-
tonomous dysregulated terminal differentiation. 
(A) Western blot of keratinocytes for expression of 
ADAM17 (AD17), TGMs 1 and 3, and loricrin (Lor) in 
A17KC keratinocytes and controls (Ctrl). n = 3.  
(B) In vitro TGM activity in 24-h suspension-cultured 
control keratinocytes (arrows) and in A17KC keratinocytes 
(n = 6). Wild-type keratinocytes probed with an excess 
of EDTA served as negative control. Bar, 20 µm. Results: 
mean ± SD, students t test: *, P < 0.05; **, P < 0.01.
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strong reduction of serine protease 
activities, which can be caused by 
decreased protease expression or in­
creased expression of inhibitors. A skin 
DNA microarray from P10 skin of 
A17KC animals showed up­regulation 
of two serine protease inhibitors, 
serpina3a and a3n, compared with 
controls, which was confirmed by 
quantitative RT­PCR (Fig. 2 F).
Dysregulated terminal 
differentiation in A17KC skin
To elucidate whether the altered 
expression of terminal differentiation 
markers is cell autonomous, we ana­
lyzed their protein expression in a 
suspension culture of extracellular matrix (ECM)–disrupted 
primary A17KC keratinocytes and controls (Wakita and 
Takigawa, 1999; Cheng et al., 2010). A17KC keratinocytes 
showed significantly reduced levels of the TGMs 1 and 3 and 
concomitantly increased loricrin production (Fig. 3 A), sug­
gesting cell­autonomous regulatory mechanisms. Furthermore, 
the TGM activity in A17KC keratinocytes was strongly re­
duced in suspension cultures (Fig. 3 B).
Skin barrier defects in A17KC animals induce IL-36, 
immune cell influx, and hyperproliferative epidermis
The microarray analysis on P10 skin identified the IL­1 family 
member IL­36 as the most prominent proinflammatory cyto­
kine in A17KC skin. A quantitative PCR (qPCR) analysis for 
several IL­1 family members (IL­1, IL­1, IL­1ra, IL­36, 
IL­36, IL­36Ra, IL­18, and IL­18bp) showed no elevation at P2 
and P6, in contrast to the significant increase of the keratinocyte­ 
derived cytokines IL­36, IL­36, and IL­18 (Blumberg et al., 
2007; Sims and Smith, 2010) at P10 (Fig. 4 A). qPCR from 
Moreover, quantitative RT­PCR analysis revealed similar 
expression of both TGMs at P2 (not depicted) but signifi­
cantly reduced expression at P10 in A17KC skin compared 
with controls (Fig. 2 C). An immunoblot of P10 skin showed 
significant reduction of TGM3 in A17KC animals but com­
parable TGM1 levels (Fig. 2 D). Finally, there was a thick­
ened stratum corneum (not depicted) and elevated CE 
numbers in A17KC skin (Fig. 1 I, right), similar to the hyper­
keratotic stratum corneum with significantly improved 
TEWL found in TGM1/ skin grafts on nude mice as a 
compensatory mechanism for the skin permeability defects 
(Kuramoto et al., 2002).
Thickening of the cornified layer can be caused by re­
duced desquamation of corneocytes, which depends on pro­
cessing by kallikreins (Eissa and Diamandis, 2008). When we 
probed A17KC skin sections with fluorescently labeled soy­
bean protease inhibitor (SBTI), which binds kallikreins (Franzke 
et al., 1996), we found significantly reduced staining in the 
A17KC stratum corneum at P10 (Fig. 2 E). This indicates a 
Figure 4. Skin barrier defects result in 
increased IL-36, immune cell infiltra-
tion, and epidermal thickening. (A) qPCR 
analysis of P2-P19 skin for IL-36, IL-36, 
and IL-18. (B) qPCR analysis of P10 epider-
mis for IL-36, IL-36, and IL-18 (n = 4).  
(C) qPCR analysis of P2–P19 skin for CCL2, 
and CXCL1 relative to GAPDH. n ≥ 3.  
(D) Flow cytometry of skin cell suspensions 
gated for CD45+ and further analyzed for 
neutrophils (CD11b+Ly6G+) and inflammatory 
macrophages (CD11b+Ly6GLy6C+F4/80+). 
P10 (n = 5), P15 (n = 4), and P19 (n ≥ 8)  
are shown. (E) Sections of H&E-stained 
A17KC skin at P21 showed neutrophil ac-
cumulation on the surface and adjacent to 
hair follicles (black arrows). (F) Percentage 
of Ki67-positive keratinocytes in A17KC skin 
at P21 (n = 3). Bars, 50 µm. Results: mean ± 
SD. Student’s t test: *, P < 0.05; **, P < 0.01; 
***, P < 0.001.
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cell infiltrates were detectable, the prolifer­
ating basal keratinocyte layer showed no 
changes (not depicted). At P21 there was 
significant epidermal hyperplasia with in­
creased numbers of Ki67­positive cells 
(Fig. 4 F), coinciding with increased 
immune cell infiltrates.
Inflammatory macrophages are not  
the primary cause of the skin barrier 
defect of A17KC mice
The development of hyperproliferative skin 
diseases can potentially be triggered by skin 
macrophages (Stratis et al., 2006). However, 
the absence of inflammatory macrophages at P10 when epithe­
lial barrier defects first became evident argued against such a 
mechanism in A17KC mice. Yet because inflammatory macro­
phages were present at an early stage of barrier breakdown and 
preceded infiltration of neutrophils (Fig. 4 D), a significant con­
tribution of macrophages as a primary cause of the epithelial 
barrier defects was still possible. To address this possibility, we 
depleted the macrophages in A17KC skin by subcutaneous in­
jection of clodronate­loaded liposomes starting at P8—before 
appearance of the first signs of the phenotype—until P19. This 
treatment dramatically reduced the number of macrophages in 
the dermis compared with PBS­liposome treated A17KC lit­
termates (Fig. 5, A and B, top) but did not improve epidermal 
TGM activity (Fig. 5 B, bottom) or the TEWL (Fig. 5 C).
EgfrKC mice have similar epidermal barrier defects  
and dysregulated keratinocyte differentiation  
to those of A17KC mice
ADAM17 is the principal sheddase for several ligands of the 
EGFR (Peschon et al., 1998; Jackson et al., 2003; Blobel, 2005; 
Sternlicht et al., 2005). Western blot analysis of phosphory­
lated EGFR (pEGFR) revealed a pronounced reduction of 
pEGFR in A17KC skin lysates with similar levels of total 
EGFR (Fig. 6 A). Egfr/ mice have defects in hair and 
epidermis splits confirmed their epidermal origin (Fig. 4 B). 
Thus A17KC keratinocytes begin to express proinflammatory 
cytokines at the onset of detectable epidermal barrier defects. In 
addition, the expression of the monocyte chemoattractant pro­
tein 1/CCL2 in the skin was significantly increased from P10, 
whereas the neutrophilic chemokine GRO­/CXCL1 showed 
increased expression at P16 (Fig. 4 C).
To evaluate the potential consequences of increased cyto­
kine and chemokine expression in the skin of A17KC mice, 
we used histochemistry and flow cytometry of single­cell sus­
pensions from skin to identify infiltrating immune cells. No 
infiltrating immune cells were detectable at P10, but a signifi­
cant increase in inflammatory macrophages (defined as CD45+
CD11b+Ly6GLy6C+F4/80+) was evident at P15 (Fig. 4 D, 
top). At P19, there was a strongly increased infiltration of 
neutrophils (identified as CD45+CD11b+Ly6G+) and inflam­
matory macrophages (Fig. 4 D) and significantly elevated 
numbers of mast cells (not depicted). In contrast, there was no 
detectable elevation of CD3+ T cell or CD19+ B cell popula­
tions (unpublished data). Histological analysis of trunk and ear 
skin of A17KC mice at P21 showed significant neutrophilic 
infiltrates on the skin surface or close to the hair follicle canals 
(Fig. 4 E). The inflammatory responses in the skin most likely 
led to keratinocyte proliferation. At P10, when no immune 
Figure 5. Infiltrating skin macrophages do not 
cause the skin barrier defects in A17KC mice. 
For depletion of dermal macrophages, A17KC mice 
were subcutaneously injected with clodronate-
loaded liposomes (A17KC + Clod) or PBS-loaded 
liposomes (A17KC + PBS, Ctrl) into the back skin. 
(A) Flow cytometry of skin macrophages at P19 
gated for CD11b+Ly6G and further analyzed for 
skin macrophages (CD45+F4/80+; n = 5). (B) Immuno-
fluorescence staining of A17KC skin with anti-
F4/80 antibodies to detect macrophages (top) and 
for TGM activity (bottom, arrows in Ctrl; n ≥ 5 per 
group). Bars, 20 µm. (C) TEWL from the back skin of 
A17KC mice injected with clodronate-loaded 
(A17KC + Clod) or control (A17KC + PBS) liposomes 
and from control mice was detected from P8 to P19 
(n ≥ 5 per group). Data are mean ± SD. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.
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penetrance of open eyes at birth, de­
layed hair outgrowth, shortened and 
disorganized hair follicles at P10, and 
dry scaly skin on the face, scalp, ven­
tral upper trunk, and tail at P19 (un­
published data). EgfrKC mice showed 
85% lethality between P18 and P25, 
with survivors living up to 6 mo 
(Fig. 6 C) with pronounced growth 
retardation and 50% of maximal 
weight loss (Fig. 6 D). EgfrKC mice 
had significant dye penetration on the face, upper trunk, and 
paws at P15 (Fig. 6 E) and significant TEWL at P10, which 
was strongly elevated at P19 (Fig. 6 F). Similar to A17KC 
mice, we found a significant reduction of the late terminal 
differentiation marker involucrin in the EgfrKC epidermis 
(Fig. 6 G) and increased keratin1 and loricrin mRNA ex­
pression (not depicted). Moreover, TGM activity was un­
changed in the epidermis of EgfrKC mice at P2 (not depicted) 
but significantly reduced at P10 compared with controls 
(Fig. 6 H). Analysis of cytokine expression in the skin of 
EgfrKC mice showed no elevation of IL­1, IL­1, IL­1ra, and 
IL­36Ra, but significantly elevated IL­36 and Ccl2 at P12 
(Fig. 6 I) and induction of Cxcl1, as well as strongly in­
creased neutrophil and inflammatory macrophage infiltrates 
at P19 (Fig. 6, I and J; and not depicted). Thus the pathologi­
cal changes in EgfrKC mice closely resembled those ob­
served in A17KC mice.
epithelial development (Miettinen et al., 1995; Sibilia and 
Wagner, 1995; Sibilia et al., 2003) resembling those in 
A17KC mice; however, the effects of EGFR deficiency on 
epidermal barrier and CE formation have not been previ­
ously investigated.
Previously described EgfrKC mice in a SV129/CL57BL6/
FVB background were viable and fertile with wavy hair 
(Lee and Threadgill, 2009), although the severity of EGFR 
knockout mice phenotypes depends on the genetic back­
ground (Sibilia and Wagner, 1995; Threadgill et al., 1995). 
Therefore, we generated EgfrKC mice in the SV129/
CL57BL6 background of the A17KC mice. Lack of EGFR 
expression in epidermal splits was confirmed by immuno­
blot (Fig. 6 B). Furthermore, expression of ADAM17 in EgfrKC 
skin was comparable with littermate controls (unpublished 
data). EgfrKC mice developed very similar phenotypes to 
those of A17KC mice, including curly whiskers and a 10% 
Figure 6. EgfrKC mice have similar 
epidermal differentiation and barrier 
defects as A17KC mice. (A) Western blot 
of A17KC skin lysates for phospho-EGFR 
(pEGFR) and total EGFR compared with 
controls (Ctrl; n = 4). (B) Immunoblot analy-
sis of epidermal splits of EgfrKC skin for 
EGFR. (C) Survival curve of control (Crtl) 
versus EgfrKC littermate mice (n = 30). 
Mantel-Cox test: ***, P < 0.001. (D) Body 
weight of EgfrKC versus control mice at 
different ages (n ≥ 4). (E) Pronounced tolu-
idine blue dye penetration around the snout 
and the upper trunk of P15 EgfrKC animals 
(representative of three animals). (F) TEWL 
from EgfrKC mice compared with controls 
at P10 and P19 (n ≥ 4). (G) Western blot of 
P3 back skin with involucrin antibodies in 
EgfrKC versus control skin (Ctrl). n ≥ 3.  
(H) In situ TGM activity (arrows) in P10 skin 
from EgfrKC epidermis compared with con-
trols (Ctrl; n = 3). The dashed line represents 
the basement membrane. Bar, 20 µm.  
(I) qPCR with total RNA from P7, P12, and 
P19 skin for IL36, Ccl2, and Cxcl1. (J) Flow 
cytometry of P19 skin cell suspensions for 
neutrophilic infiltrates (CD45+CD11b+Ly6G+; 
n = 6). Results: mean ± SD. Student’s t test: 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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We therefore sought to determine whether TGF­ is 
involved in the differentiation of primary keratinocyte cul­
tures. When we used a Ca2+­induced keratinocyte differen­
tiation assay (Pillai and Bikle, 1991), we found that Ca2+ 
treatment increased the release of TGF­ from keratinocytes 
by 50% compared with untreated controls (Dlugosz et al., 
1994; not depicted). When suspension cultures of keratino­
cytes (Wakita and Takigawa, 1999; Cheng et al., 2010) were 
treated with 30 ng/ml TGF­ for 48 h, we found signifi­
cantly reduced keratin 1 and loricrin mRNA expression, 
whereas keratin 14 expression remained unchanged (Fig. 7 A). 
Thus, stimulation of the EGFR by TGF­ had the opposite 
effect on the keratinocyte differentiation markers keratin1 
and loricrin as deletion of ADAM17 (Fig. 2 A). Importantly, 
the reduced TGM activity in ECM­disrupted A17KC kera­
tinocytes was nearly completely restored by recombinant 
TGF­ (Fig. 7 B), suggesting that the lack of EGFR acti­
vation is the major cause of the loss of TGM activity in 
ADAM17­deficient keratinocytes.
To address the role of ADAM17/TGF­ in epidermal 
barrier maintenance in vivo, we first determined whether 
TGF­ levels are altered in A17KC skin. No differences in 
the RNA expression or protein staining were observed in the 
A17KC animals compared with controls (unpublished data). 
In addition, no significant differences in the expression of 
HB­EGF, amphiregulin, and epiregulin mRNA were found 
in A17KC mice versus controls (unpublished data). However, 
shedding of TGF­ from primary A17KC keratinocytes was 
strongly reduced compared with controls (Fig. 7 C).
To determine whether the lack of TGF­ shedding from 
the epidermis was responsible for the skin barrier break­
down and subsequent skin inflammation, we applied re­
combinant TGF­ or DMSO as control daily to a defined 
area of A17KC skin from P8 to P19 and measured EGFR 
phosphorylation, TGM activity, compensatory serine prote­
ase activity, and immune cell infiltrates. Western blot analy­
sis revealed a pronounced increase of phospho­EGFR and 
TGM3 in TGF­–treated A17KC skin (Fig. 8 A). Moreover, 
TGF­ significantly improved TGM activity in A17KC 
skin at P19 (Fig. 8 B) with 65% increased TGM3 expres­
sion. TGF­ also reversed the compensatory reduction of 
serine protease activity in the stratum corneum of P19 
mutant skin (Fig. 8 C) and reduced infiltrating neutrophils 
by 60% (Fig. 8 D) and inflammatory macrophages by 40% 
(not depicted). Furthermore, the daily application of recom­
binant TGF­ to a defined area of EgfrKC skin from P8 to 
P19 did not affect the infiltration of immune cells or TGM 
activity (unpublished data).
Chronic deficiency of keratinocyte-derived ADAM17  
results in atopic dermatitis-like disease
20% of the A17KC mice survived up to 6 mo, thus allowing 
us to examine the chronic effects of keratinocyte­ADAM17 
deficiency. Older A17KC mice displayed all characteristic 
manifestations of a defective epidermal barrier and dehydra­
tion, including dry scaly skin, significantly increased serum 
The EGFR ligand TGF- regulates epidermal differentiation
Of the EGFR ligands whose shedding depends on ADAM17 
(Sahin et al., 2004), TGF­ is mainly responsible for epi­
dermal development and hair growth (Luetteke et al., 1993; 
Mann et al., 1993; Schneider et al., 2008). Quantitative 
analysis of RNA expression level of EGFR ligands in wild­
type P2 skin revealed the highest levels for TGF­, with 
fivefold more expression than HB­EGF and 2.5­fold 
more expression than amphiregulin or epiregulin (unpub­
lished data).
Figure 7. EGFR stimulation with TGF- regulates terminal differ-
entiation. (A) ECM-disrupted keratinocyte suspensions were incubated 
with and without 40 ng/ml TGF- for 48 h, and total RNA was then ana-
lyzed by qPCR for keratin1, loricrin, and keratin14 (n = 3). (B) Suspension 
cultured keratinocytes analyzed for in vitro TGM activity (arrows). Bar, 20 µm. 
A17KC keratinocytes were cultured with 40 ng/ml TGF- when indicated 
(n = 3 per group). (C) TGF- ELISA in the supernatants of control and 
A17KC keratinocytes cultured for 24 h (n = 7). Results: mean ± SD.  
Student’s t test: *, P < 0.05; ***, P < 0.001.
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depicted), and severely decreased bone 
marrow B220+ populations (Fig. 9 E) 
in P60 A17KC mice compared with 
controls. Similar pathological changes 
were observed in the skin of P60 
EgfrKC mice (Fig. 9 B­E), suggesting 
that impaired EGFR signaling causes 
these defects in A17KC mice.
DISCUSSION
The skin provides an important pro­
tective physical barrier, yet the mo­
lecular mechanisms responsible for 
maintaining this barrier remain poorly 
understood. Here we report that the 
ADAM17–EGFR signaling axis in keratinocytes regulates 
the integrity of the skin barrier by promoting terminal kerati­
nocyte differentiation and the cross­linking activity of TGMs. 
Lack of ADAM17 in keratinocytes led to severe epidermal 
barrier defects, resulting in TEWL, inflammatory infiltrates, 
and increased mortality. ADAM17 regulates the skin barrier 
by controlling EGFR ligand shedding and EGFR signaling in 
keratinocytes, as indicated by lack of TGF­ shedding from 
A17KC keratinocytes and the similar phenotype of EgfrKC 
and A17KC mice. Notably, application of TGF­ to A17KC 
skin restored epidermal barrier integrity by stimulating skin 
TGM activity and thereby reducing immune infiltrates. Our 
findings highlight the essential role of the ADAM17–TGF­ 
(or other EGFR ligands)–EGFR signaling pathway in main­
taining epidermal barrier homeostasis.
The integrity of the epidermal barrier depends on the 
continuous regeneration of the cornified layer. Cornification 
is a tightly controlled process, which requires coordinated 
keratinocyte proliferation, detachment, migration and cell 
death by terminal differentiation. A striking finding in the 
epidermis of the A17KC animals was the defect in termi­
nal keratinocyte differentiation and cornified layer forma­
tion, which was very similar to that observed in EgfrKC mice. 
The release of the ADAM17 substrate and EGFR ligand TGF­ 
was increased in differentiating wild­type keratinocytes, and 
sodium, reduced skin turgor, and 50% weight loss (unpub­
lished data). Furthermore, compared with control littermates, 
they exhibited strong scratching as a sign of intense pruritus, 
which is characteristic of chronic dermatitis with epidermal 
barrier defects (Habif, 2009). Histological analysis confirmed 
altered epidermal differentiation, with increased expression 
of keratin 1 and loricrin and lower expression of involucrin, 
one of the initiator proteins in the cornification, suggesting 
dysregulated terminal differentiation (Fig. 9 A). Long­term 
surviving A17KC mice also demonstrated pronounced epi­
dermal hyperproliferation, similar to A17KC animals at P21 
(Fig. 4 F), with increased cell numbers, keratin14, keratin1, 
and epidermal staining of the hyperproliferation marker kera­
tin 6, which is normally only produced in the midportion of 
the hair follicles of control skin (Fig. 9 A). In addition, tolu­
idine blue staining and flow cytometry of back skin of 60­d­
old mice revealed pronounced dermal accumulation of mast 
cells (Fig. 9 B), and strongly elevated numbers of inflamma­
tory macrophages (CD45+CD11b+Ly6G­F4/80+) and T cell 
populations (CD3+; not depicted). The epidermal thickening 
was most likely induced by the severe infiltration of inflam­
matory cells. The prolonged skin inflammation of the A17KC 
mice presumably also caused systemic defects with significantly 
increased serum concentrations of IgE und IgG1 (Fig. 9 C), 
splenomegaly (Fig. 9 D) and enlarged lymph nodes (not 
Figure 8. Application of TGF- recon-
stitutes the skin barrier. (A) Immunoblot 
analysis of DMSO control versus TGF-–
treated A17KC skin (n = 4). (B) TGM activity 
(arrows) in P19 control or A17KC skin treated 
with TGF- (n = 5 per group). (C) Serine pro-
tease activity (detected with SBTI Alexa Fluor 
488 conjugates; arrows) in control or A17KC 
skin treated with TGF- (n = 3). The dashed 
lines in B and C represent the basement 
membrane. (D) For flow cytometric detection, 
the skin cell suspensions were gated for 
CD45 and further analyzed for neutrophils 
(CD11b+Ly6G+; n = 8 per group). Results: 
mean ± SD. Student’s t test: *, P < 0.05;  
**, P < 0.01; ***, P < 0.001. Bars, 20 µm.
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of EGFR or ADAM17 deficiency in 
all tissues. Our findings suggest that 
ADAM17/EGFR signaling in kera­
tinocytes only plays a minor role in 
the development of an intact skin 
barrier in utero and in newborn mice 
but that it is crucial for the renewal of 
the CE in postnatal development and 
adults. Consistent with our findings 
of a normal epidermal barrier in 
newborn A17KC and EgfrKC mice, 
the TGM activity, necessary for cross­
linking of proteins and formation of 
the CE, was normal at birth but sig­
nificantly decreased at P10. Interest­
ingly, control littermates had strongly 
elevated expression of TGM1 and 
TGM3 (unpublished data) and increased TGM activity at P10 
compared with P2, suggesting an increased importance of 
TGMs in forming and maintaining the CE as the animals 
grow older. Consistent with this, about a threefold increase in 
TGM activity was detected in adult murine skin compared 
with P2 skin (Kagehara et al., 1994). The reduction of both 
TGM transcripts in A17KC skin at P10 and in ADAM17 de­
ficient keratinocytes indicate that both TGMs are regulated 
cell autonomously by EGFR signaling, as further corrobo­
rated by enhanced TGM expression and activity after treat­
ment with TGF­. Interestingly, the severity of autosomal 
recessive congenital ichthyosis, a disorder of keratinization 
caused by mutations in TGM1, correlated with the decrease 
in skin TGM activity (Akiyama et al., 2003).
The reduced TGM activity in A17KC epidermis resulted 
in the production of an immature CE and denser stratum cor­
neum with significantly increased numbers of corneocytes. 
The strongly reduced serine protease activity in the cornified 
TGF­ stimulated the differentiation of suprabasal­like kera­
tinocytes, as indicated by reduced keratin 1 and loricrin and 
increased TGM expression (Dlugosz et al., 1994; Peus et al., 
1997; Wakita and Takigawa, 1999; Cheng et al., 2010). Ac­
cordingly, A17KC keratinocytes had increased loricrin levels 
and decreased TGM expression. These findings implicate 
ADAM17 in cell­autonomous regulation of keratinocyte dif­
ferentiation and regeneration of the cornified layer through 
shedding of TGF­.
Previous studies revealed immature or absent keratini­
zation of the stratum corneum in newborn Egfr/ mice 
(Miettinen et al., 1995; Sibilia and Wagner, 1995). In con­
trast, in our study both A17KC and EgfrKC animals were born 
with normal epidermal barrier integrity. The severe inside­
out barrier defects with significant TEWL and the outside­in 
barrier defects only became evident around postnatal day 10. 
The more severe phenotype of Egfr/ and Adam17/ knock­
out mice is most likely explained by the compounded effects 
Figure 9. Prolonged epidermal 
ADAM17 deficiency leads to chronic 
dermatitis. (A) Immunohistological staining 
of P60 epidermis with antibodies against 
the basal keratinocyte marker keratin14, 
hyperproliferation marker keratin 6, the 
early differentiation marker keratin1, and 
the terminal differentiation markers involu-
crin and loricrin. Arrows indicate staining 
localization. (B) Toluidine blue staining of 
back skin sections revealed a pronounced 
dermal accumulation of mast cells (arrows; 
n = 4). Bars: (A and B) 50 µm. (C) Concen-
trations of IgE and IgG1, measured by ELISA 
in serum of P60 animals (n ≥ 3). (D) Spleen 
weight in control, A17KC, and EgfrKC ani-
mals (n = 14). Bar, 1 cm. (E) Anti-B220 PE-
stained B cell populations compared with 
controls in bone marrow flow cytometry  
(n ≥ 4). Data are mean ± SD. *, P < 0.05;  
**, P < 0.01; ***, P < 0.001.
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Murthy et al. (2012) recently described a similar inflamma­
tory skin phenotype in A17KC mice but proposed that it is 
caused by the loss of a putative ligand­independent Notch 
activation by ADAM17, which, in turn, would normally 
suppress the production of thymic stromal lymphoprotein 
(TSLP) in adult skin. However, another study has shown that 
TSLP is produced as a consequence of skin barrier defects in 
general and does not depend on loss of Notch signaling 
(Demehri et al., 2008). Importantly, we demonstrate that the 
invasion of inflammatory cells is a consequence of the skin 
barrier defects, and not the cause, because skin defects de­
velop in A17KC mice before inflammatory infiltrates and are 
not reversed by macrophage depletion with clodronate. 
Moreover, our study identifies EGFR­dependent regulation 
of TGMs, which are directly responsible for establishing the 
skin barrier, as the most likely basis of the skin defect in 
A17KC mice. This mechanism is further supported by the 
finding that EgfrKC mice develop chronic dermatitis and sys­
temic myeloproliferative disease, just like A17KC mice, and 
by rescue experiments of A17KC mice with the EGFR 
ligand and ADAM17 substrate TGF­. Therefore, we con­
clude that chronic dermatitis and systemic myeloproliferation 
in ADAM17 knockout mice are late manifestations of persis­
tent EGFR ligand deficiency and the resulting defective skin 
barrier. In this context, it should also be noted that previous 
studies have demonstrated both agonistic and antagonistic 
cross talk between the EGFR and Notch pathways (Yoo 
et al., 2004; Hasson et al., 2005; Doroquez and Rebay, 2006; 
Aguirre et al., 2010), suggesting that the reduced Notch sig­
naling observed by Murthy et al. (2012) in A17KC skin could 
also be explained by lack of EGFR activation. Finally, both 
A17KC and EgfrKC mice showed an outside­in barrier de­
fect, which is thought to contribute to the pathogenetic 
mechanism of atopic dermatitis by exposing the skin to 
exogenous agents or antigens, which then trigger immune 
reactions (Irvine and McLean, 2006; Moniaga et al., 2010).
Of the EGFR ligands that are shed by ADAM17 (Sahin 
et al., 2004), TGF­ is the principal growth factor required 
for epidermal differentiation and hair growth in mice (Luetteke 
et al., 1993; Mann et al., 1993) and it is the most highly ex­
pressed EGFR ligand in skin. However, other EGFR ligands 
also regulate important keratinocyte functions, such as kera­
tinocyte migration, which is stimulated by heparin binding 
EGF (HB­EGF) and increased keratinocyte proliferation in 
psoriasis­like cutaneous pathologies by amphiregulin (Schneider 
et al., 2008; Maretzky et al., 2011). It is therefore possible 
that several ADAM17­dependent EGFR ligands coordinately 
support epidermal barrier development and maintenance.
The EGFR signaling pathway is an established target for 
treatment of various cancers (Hynes and Lane, 2005). Interest­
ingly, dermatologic side effects frequently appear during the 
first 3 wk of treatment, especially on skin regions with high 
density of sebaceous glands, like the scalp, face, and upper chest. 
These side effects include inflammatory papulopustular 
acneiform rash, hair changes, itching (pruritus), and skin dry­
ness (xerosis), whereas the mostly sterile inflammatory rash 
layer is likely a consequence of the decreased TGM activity 
because serine protease and TGM activity were normal in P2 
A17KC skin. Previous studies have shown that a reduced in­
tegrity of the cornified layer can be associated with a compen­
satory decrease in desquamation, resulting in a thickened 
stratum corneum that maintains skin barrier function. This 
effect has been documented in Tgm1/ skin grafts on nude 
mice, which formed a hyperkeratotic stratum corneum with 
significantly reduced TEWL (Kuramoto et al., 2002). Desqua­
mation is an active process, which depends on a well balanced 
degradation of the corneodesmosomal adhesion molecules by 
the serine proteases kallikrein 7 and 5, which in turn are acti­
vated by other kallikreins (Eissa and Diamandis, 2008). Thus 
the decreased serine protease activity in the A17KC skin is 
most likely responsible for the reduced desquamation. Interest­
ingly, kallikreins were not down­regulated in microarrays of 
A17KC skin (unpublished data) but instead serpina3 members 
were up­regulated, which can irreversibly inhibit several kalli­
kreins and thereby regulate corneocyte detachment (Caubet 
et al., 2004; Ny and Egelrud, 2004; Baker et al., 2007).
The expression of proinflammatory cytokines in kerati­
nocytes was most likely triggered by epidermal barrier defects 
because it increased at the same time that significant TEWL 
on the skin surface first became apparent and coincided with 
reduced TGM activity in A17KC skin. Previous studies have 
shown that acute skin barrier defects led to epithelial cytokine 
production, especially of IL­1 family members (Wood et al., 
1992; Ye et al., 2002; Yang et al., 2010). We found that skin 
barrier defects in A17KC preferentially up­regulated the ex­
pression of the novel IL­1 family member IL­36 (Sims and 
Smith, 2010) and, to a lesser degree, IL­36 and IL­18. We 
detected similar IL­1 family member expression patterns 
in the skin of EgfrKC animals. The proinflammatory effects of 
IL­36 have been demonstrated in vivo by transgenic 
overexpression of IL­36 in the epidermis (Blumberg 
et al., 2007) and by the development of generalized pustular 
psoriasis in patients with an inactivating mutation in the 
IL­36 receptor antagonist (IL­36Ra), a protein which normally 
blocks activation of the IL­36 receptor (also referred to as 
IL­1 receptor­related protein type 2; IL­1Rrp2) by IL36, , 
and  (Marrakchi et al., 2011). Interestingly, pronounced 
epidermal expression of IL­36 was previously reported in 
epidermis­specific FGFR1/FGFR2 double knockout mice, 
which develop progressive skin barrier defects associated with 
immune cell infiltrates, comparable with the A17KC mice 
(Yang et al., 2010). Recent studies have shown that the 
FGFR2 activates the EGFR and ERK1/2 by stimulating 
ADAM17 and release of EGFR ligands, providing a possible 
explanation for the similar phenotypes of FGFR1/FGFR2 
double knockout mice and A17KC mice (Maretzky et al., 
2011). Thus, our findings support a model in which EGFR 
signaling in the epidermis has immunoregulatory functions 
by maintaining terminal keratinocyte differentiation.
Over time, the surviving A17KC mice developed a 
chronically thickened epidermis, dry skin, severe inflammatory 
dermal infiltrates, and systemic myeloproliferative disease. 
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37°C overnight, and subsequently embedded in paraffin. The tissue sections 
were counterstained with eosin.
Quantitative RT-PCR analysis. Total RNA from mouse skin, epider­
mal splits, or primary keratinocyte cultures was extracted using RNeasy 
(QIAGEN). 1 µg of total RNA was reverse transcribed using a First Strand 
cDNA Synthesis kit (Fermentas). Relative quantification of gene expres­
sion was performed by real­time qPCR using iQ SYBR­green Supermix 
on a Thermal Cycler (CFX96 C1000; Bio­Rad Laboratories) according 
to the manufacturer’s protocols. All primer sequences are shown in Table S1. 
Relative expression was normalized for levels of GAPDH. The genera­
tion of the correct amplification products was confirmed using agarose 
gel electrophoresis.
Primary keratinocyte preparation and cultivation. Keratinocytes 
were isolated from the skin of A17KC or EgfrKC mice and their wild­type 
littermates essentially as described (Franzke et al., 2009). In brief, the skin 
was washed with PBS containing 1% antibiotic­antimycotic (Invitrogen, 
Germany), and epidermis and dermis were detached by overnight diges­
tion with dispase (STEMCELL Technologies) at 4°C. The epidermis was 
incubated with 0.25% trypsin (wt/vol) and 2 mM EDTA for 30 min at 
37°C under vigorous shaking. After stopping the reaction with PBS 
containing 10% FCS, the keratinocyte suspension was passed through a 
45­µm sieve, and 105 cells/cm2 were plated in defined serum­free keratino­
cyte medium (CellnTec) supplemented 100 U/ml penicillin and 100 µg/ml 
streptomycin (Invitrogen). The cells were maintained in defined serum­
free keratinocyte medium at 37°C in 5% CO2, and medium was replaced 
every 48 h. Subconfluent cells derived from passages 1–3 were used for 
the experiments.
Keratinocyte cell suspension cultures. Suspension culture on poly­
hydroxyethyl­methacrylate (poly­HEMA)–coated plates was performed as pre­
viously described (Wakita and Takigawa, 1999). 6­well plates were coated 
with poly­HEMA (Sigma­Aldrich), followed by extensive PBS washes. 2 ml 
of cell suspension was added in each coated well and incubated in a humidi­
fied incubator with 5% CO2 in air at 37°C for 24 or 48 h. After centrifuga­
tion the cell pellets were either used for the preparation of cell lysates or total 
RNA extraction or for the in vitro detection of TGM activity. For the 
detection of TGM activity, we attached 24­h suspension­cultured keratino­
cytes on gelatin­coated coverslips and preincubated them with 1% BSA in 
0.1M Tris­HCl, pH 7.4, for 30 min at room temperature. Afterward, we 
detected the TGM activity as described in the Enzyme activity assays section.
Histology. Tissues were fixed in 3.7% buffered formaldehyde or 4% PFA 
and embedded in paraffin. 5­µm sections were stained with hematoxylin and 
eosin (H&E) and toluidine blue.
Immunohistochemistry. Paraffin sections or cryosections of 5 µm were 
stained using mAb against Ki67 (1:50; clone TEC­3; Dako), keratin 14 
(1:200; clone LL001; Santa Cruz Biotechnology, Inc.), and polyclonal 
rabbit antibodies against human TGF­ (1:50; R&D systems), keratin1 
(1:1,000; Abcam), loricrin (1:1,000; GeneTex), keratin 6, involucrin 
(1:500; Covance), and TGM1 and TGM3 (both 1:100; Santa Cruz Bio­
technology, Inc.). For visualization, the sections were incubated with 
either biotinylated secondary anti–mouse IgG or anti–rabbit IgG anti­
bodies (Dako) using the VECTASTAIN ABC kit and Nova RED substrate 
kit (Vector Laboratories) or with Alexa Fluor 488– or Alexa Fluor 594–
conjugated secondary antibodies (Invitrogen), followed by embedding 
with mounting medium supplemented with DAPI (Vector Laboratories). 
Epidermal lipids in skin cryosections were visualized using 2.5 µg/ml Nile 
red for 2 min at RT. Specimens were viewed with a brightfield and epifluor­
escence microscope (Axio Imager A1 equipped with AxioCam MRm 
and MRc cameras; Carl Zeiss) using AxioVision software (version 4.8.2; 
Carl Zeiss) and processed using ImageJ software (version 1.43u; National 
Institutes of Health).
accompanied with itchy xerotic skin is the most frequent mani­
festation (Pastore and Mascia, 2008; Lacouture et al., 2011). 
Recently, similar anti­EGFR antibody­induced neutrophil­
rich skin inflammation combined with epithelial thickening of 
the face und upper trunk has been reported in immunodeficient 
(SCID) mice after the 3rd wk of treatment (Surguladze et al., 
2009). Although the clinical manifestations are well character­
ized, the direct mechanistic cause of these inflammatory skin 
reactions is still unclear (Lacouture, 2006). Because depletion of 
ADAM17 or the EGFR in the epidermis lead to xerotic 
inflammatory skin, preferentially at sites with high density of 
sebaceous glands, it is likely that the gene­targeted mice and 
patients share the same mechanistic cause of epidermal pathol­
ogy. This notion is further supported by a recent report of the 
first inactivating mutation in the ADAM17 gene borne by a 
human patient, who has developed an inflammatory skin and 
bowel disease with neonatal onset, strongly elevated T cell skin 
infiltrates, and reduced TGM1 expression in the skin (Blaydon 
et al., 2011). Thus, the insights gained from A17KC mice have 
significant translational relevance. Understanding the biological 
consequences of the blockage of ADAM17­dependent EGFR 
signaling in the skin could lead to the development of better 
therapeutic strategies for the dermatologic side effects of EGFR 
antagonists in cancer patients and the treatment of patients car­
rying mutant alleles of ADAM17.
MATERIALS AND METHODS
Animals. The generation of Adam17flox/flox and EGFRflox/flox mice has been 
described previously (Horiuchi et al., 2007; Lee and Threadgill, 2009). Both 
strains were crossed with keratin­14­Cre (Krt14-Cre) transgenic mice 
(004782, STOCK Tg(KRT14­cre)1Amc/J; The Jackson Laboratory). 
Adam17flox/+Krt14-Cre mice were crossed with Adam17flox/flox mice to gener­
ate Adam17flox/flox Krt14-Cre mice, referred to as A17KC. An essentially iden­
tical approach yielded Egfrflox/flox Krt14-Cre mice, referred to as EgfrKC. In 
both cases, the genotypes of the offspring followed a Mendelian distribution. 
Transgenic ROSA26-LacZ reporter mice were from The Jackson Labora­
tory (003309, B6.129S4­Gt(ROSA)26Sortm1Sor/J). All mice were of 
mixed genetic background (129Sv, C57BL/6), and all comparisons were be­
tween littermates. Serum sodium concentrations were measured on a Chem­
istry Analyzer (AU400; Beckman Coulter). In some experiments, mice 
received daily applications of TGF­ (1.5 µg/mouse) or vehicle (80% DMSO in 
PBS) on their ventral neck and one ear. For depletion of skin macrophages, 
we subcutaneously injected 100 µl of Clodronate­loaded liposomes or PBS­
loaded liposomes as control every other day into the back skin of A17KC or 
EgfrKC mice and their control littermates starting at P8 until P18. Clodronate­ 
or PBS­loaded liposomes were prepared as described previously (van Rooijen 
and van Kesteren­Hendrikx, 2003). The mice were maintained in the 
Hospital for Special Surgery (HSS) Animal Facility and at the Biomedical 
Research Centre of the University Medical Center in Freiburg, and all 
experiments were performed according to the guidelines of the American 
Veterinary Association and the German Animal Welfare association and ap­
proved by the HSS Internal Animal Care and Use Committee or the Regier­
ungspräsidium Freiburg.
Tissue histology of the Krt14-Cre/ROSA26Lac-Z reporter mice. 
The tissue expression pattern of the keratin 14 promoter was analyzed 
using offspring of matings of Adam17wt/floxKrt14-Cre mice with Adam17flox/flox 
ROSA26-lac-Z mice (R26R), which express ­galactosidase upon Cre­
mediated excision of a loxP­flanked STOP codon. The tissues taken from 
P14 or P28 animals were fixed with 4% PFA in PBS for 2 h and incubated 
with 5­bromo­4­chloro­3­indolyl ­d­galactosidase staining solution at 
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under vigorous shaking and the cell suspension was passed through a 45­µm 
sieve, and the cells were stained with the following antibody conjugates: bio­
tinylated anti­CD45, anti­CD115 PE, anti­CD11b PE­Cy7 (eBioscience), 
anti­CD3 FITC, anti­B220 PE, anti­CD19 PE, anti­CD117 PECy7, anti­
FcRI PE, anti­Ly6G FITC, anti­Ly6C PerCP­Cy5.5 (BD), and anti­
F4/80 APC (Serotec). Biotin­conjugated Abs were revealed with Streptavidin 
eFluor 450 (eBioscience). Data were acquired and analyzed on a Beckman 
Coulter Gallios instrument using Kaluza software (Beckman Coulter).
Microarray processing and data analysis. Total RNA from P10 full back 
skin of either two A17KC or two wild­type littermate mice was prepared 
using the RNeasy Fibrous Tissue Mini kit (QIAGEN). After determination of 
the RNA concentration (NanoDrop ND­1000; Wilmington) and of RNA 
quality with a 2100 Bioanalyzer (Agilent Technologies), the samples were fur­
ther processed for transcriptome analyses with the Agilent 4 × 44K whole 
mouse genome oligo expression microarray kit (Design ID 014868) according 
to the Agilent One­Color Microarray­Based Gene Expression Analysis proto­
col. The raw data were analyzed using GeneSpring GX 10.0 (normalization: 
shift to 75th percentile, baseline transformation: median of all samples). The 
microarray data can be found at the Gene Expression Omnibus under accession 
no. GSE38830. The normalized data were filtered to exclude probes flagged ab­
sent in all samples. The remaining probes were tested for statistical significance of 
expression using a two­sample Student’s t test (unpaired) with asymptotic p­value 
computation and a cut off of 0.05. Multiple testing correction was performed 
according to Benjamini­Hochberg (Klipper­Aurbach et al., 1995; P ≤ 0.05). The 
cutoff for the fold change is ≤2 (1 log2) up­ or down­regulation.
Statistics. All parametric data are present as mean ± SD. Data of two groups 
were analyzed for significance using the Student’s t test and the statistical 
analysis of survival curves was performed using the Mantel­Cox test. Both 
calculations were performed with Prism version 5.0 (GraphPad Software). 
For all analyses, n = number of experiments, and differences are considered 
to be statistically significant at P < 0.05.
Online supplemental material. Table S1 lists the primer sequences used 
for quantitative RT­PCR analysis. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20112258/DC1.
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